Marker Therapeutics, Inc (MRKR) insider trading
Every open-market stock purchase and sale by Marker Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: New Enterprise Associates 16 L.P. (Insider), $1.8M, 21 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent MRKR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Nov 17, 2025 | Steve Elms (Director) | Bought (not open market) | — |
| Nov 17, 2025 | Norman David Eansor (Director) | Bought (not open market) | — |
| Nov 17, 2025 | Norman David Eansor (Director) | Bought (not open market) | — |
| Nov 17, 2025 | Katharine Knobil (Director) | Bought (not open market) | — |
| Nov 17, 2025 | Katharine Knobil (Director) | Bought (not open market) | — |
| Nov 17, 2025 | Steve Elms (Director) | Bought (not open market) | — |
| Oct 31, 2025 | Kathryn Penkus Corzo (Director) | Bought (not open market) | — |
| Oct 31, 2025 | Juan Vera (CEO) | Bought (not open market) | — |
Who's trading MRKR
- Steve Elms, Director: other filings, last Nov 17, 2025
- Norman David Eansor, Director: other filings, last Nov 17, 2025
- Katharine Knobil, Director: other filings, last Nov 17, 2025
- Kathryn Penkus Corzo, Director: other filings, last Oct 31, 2025
- Juan Vera, CEO: other filings, last Oct 31, 2025
Get free alerts when an insider at Marker Therapeutics, Inc files a new trade →